Picture of Intuitive Investments logo

IIG Intuitive Investments Share Price

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m+5.98%
3m+11.98%
6m+92.32%
1yr+134.88%
Volume Change (%)
10d/3m+15.04%
Price vs... (%)
52w High-13.46%
50d MA+4.64%
200d MA+25.66%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-27.93%
Return on Equity-27.66%
Operating Margin119.51%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Sep 202430th Sep 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Intuitive Investments EPS forecast chart

Profile Summary

Intuitive Investments Group plc is a United Kingdom-based closed-end investment company, which is focused on the life sciences sector. The Company’s investment objective is to generate capital growth over the long term through investment in a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the United Kingdom, continental Europe, and the United States. The Company invests in early and late-stage life sciences businesses. It invests in the form of equity and equity-related instruments, including convertible debt instruments. The Company may acquire investments directly or by way of holdings in intermediate holding or subsidiary entities. The Company categories investment opportunities into sub-sectors in life sciences, such as diagnostics and healthcare, medical devices, tools and technologies, biotherapeutics and pharmaceuticals. Its adviser is SP Angel Corporate Finance LLP.

Directors

    Last Annual
    September 30th, 2023
    Last Interim
    September 30th, 2023
    Incorporated
    June 11th, 2020
    Public Since
    December 14th, 2020
    Sector
    Collective Investments
    Industry
    Financials
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    202,293,166

    IIG Share Price Performance

    FAQ